Ch𓆏ina’s healthcare sector kept growing over the second quarter of 2019. The period was characterised by increased government spending on healthcare, with the 🎶amount dedicated to health and family planning rising by 5.9% y/y to RMB 534.5bn in Q2 ...

The first quarter of 2019 witnessed a continuous growth of China’s healthcare sector. The country promoted the implementation of the Healthy China🍸 Initiative, as well as ongoing structural reforms in the sector. The period was characterized by ...

China’s healthcare sector continued to grow in Q4 2018, largely st♏imulated by the expansion of online healthcare services. The growth was attributed to increasing demand for quality healthcar♉e, driven by the country’s strong economic ...

China is the world’s second largest pharm♚aceutical market after the US and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large share of ageing ...

With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of t𓃲his report. However, the two countries differ widely in terms of per capita GDP, with that of China being more than twice that ...

In the third quarter of 2018, China’s pharmaceutical and medicine production declined by 28.5% y/y to 573⛦,000 tonnes, In 2018, many pharmaceutical producers were affected by the ongoing reform for new chemical drugs classification system, and ...

The third quarter of 2018 witnessed a continuous growth of China’s ꦡhealthcare sector, mostly driven by the online healthcare segment. The growth was attributed to increasing demand for quality healthcare, stimulated by the country’s ...

In the second quarter of 2018,꧋ China’s pharmaceutical and medicine production declined by 21.1% y/y to 749,000 tonnes, while their sales volume dropped by 22.7% y/y to 753,000 tonnes. This can be linked with the more stringent environmental ...

The second🎶 quarter of 2018 witnessed a continuous growth of China’s healthcare sector. The growth was attributed to increasing demand for quality healthcare, stimulated by the country’s strong economic performance, rising incomes, ...

The first quarter of 2018 witnessed a continuous growth of China’s healthcare se꧑ctor, stimulated by government policies and regulations. The country’s total spending on health and family planning reached RMB 442.6bn, up by 7.🥀8% ...